BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Premier Specialty Network - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Premier Specialty Network
X-ORIGINAL-URL:https://psnmo.net
X-WR-CALDESC:Events for Premier Specialty Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20180311T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20181104T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20190220T180000
DTEND;TZID=America/Chicago:20190220T210000
DTSTAMP:20260602T214304
CREATED:20190207T170010Z
LAST-MODIFIED:20211208T042044Z
UID:5361-1550685600-1550696400@psnmo.net
SUMMARY:SLRA Presentation & Dinner – February 2019
DESCRIPTION:St. Louis Rheumatology Association\nWednesday\, February 20th\, 2019\n“Pathogenesis of Osteoarthritis; Outlook for new pharmacologic and stem-cell therapies”\n  \nFarshid Guilak\, Pd.D.\n6:15 – 7:00 pm Registration \n7:00 – 9:00 pm Presentation and dinner \nZodiac\, 100 Plaza\, Frontenac\, MO 63131 \nAbout the presenter\nDr. Farshid Guilak is a Professor in the Department of Orthopaedic Surgery at Washington University and Director of Research for the Shriner’s Hospitals for Children – St. Louis Shriners. He is also the co-director of the Washington University Center of Regenerative Medicine and has appointments in the Departments of Developmental Biology and Biomedical Engineering. His laboratory is pursuing a multidisciplinary approach to investigate the etiology and pathogenesis of osteoarthritis\, as a basis for the development of new pharmacologic and stem-cell therapies. \nHe is currently PI of grants from the NIH\, NSF\, DOD\, and several foundations. He has published over 300 articles in peer-reviewed journals and has co-edited four books. He is the editor-in-chief of the Journal of Biomechanics\, Associate editor for Osteoarthritis & Cartilage\, and serves on numerous other journal editorial boards. \nHe is also the President of the Orthopaedic Research Society and Chair of the Skeletal Biology Structure and Regeneration NIH Study Section\, and the first PhD member of the executive committee of the Orthopaedic Research and Education Foundation (OREF). He has won numerous national and international awards for his research and mentorship. \nThis live activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Washington University School of Medicine\, Continuing Medical Education and St. Louis Rheumatology Association.  Washington University is accredited by the ACCME to provide continuing medical education for physicians.  Washington University designates this live activity for a maximum of _1_ AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of Washington University School of Medicine\, Continuing Medical Education\, to ensure balance\, independence\, objectivity and scientific rigor in all its educational activities.  All planners\, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations.  Any potential conflicts were addressed and resolved.  All members of the CME department have nothing to disclose.  Speakers are also expected to openly disclose inclusion of discussion of any off-label\, experimental\, or investigational use of drugs or devices in their presentations. Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients.  All scientific research should conform to the generally accepted standards of experimental design\, data collection and analysis. These presentations are not an endorsement of any commercial interests. These presentations are the views and experiences of the presenters.  The presenters’ views do not represent the policy or position of Washington University School of Medicine.  Washington University School of Medicine\, Continuing Medical Education\, is the sponsor for CME credits.
URL:https://psnmo.net/event/slra-presentation-dinner-february-2019/
LOCATION:The Zodiac\, Upper Level\, 100 Plaza Frontenac\, St. Louis\, MO\, 63131\, United States
CATEGORIES:Continuing Medical Education (CME)
ORGANIZER;CN="St Louis Rheumatology Association":MAILTO:stlrheum@gmail.com
END:VEVENT
END:VCALENDAR